Japanese drug maker Takeda Pharmaceuticals' reported decision to buy Abbott Laboratories out of a joint venture suggest that although the U.S. economy is rattled, companies in other countries are looking to pick up attractive American assets at depressed-dollar prices.

Link to Article

Forbes.com